Treatment of bipolar disorder part I: a critical review of treatment guidelines. Where do we stand?

被引:0
|
作者
KN Fountoulakis
机构
[1] 3rd University Department of Psychiatry Aristotle University of Thessaloniki,Lecturer in Psychiatry
来源
关键词
Bipolar Disorder; Olanzapine; Atypical Antipsychotic; Mood Stabilizer; Common Mental Disorder;
D O I
10.1186/1475-2832-2-S1-S50
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Treatment guidelines for bipolar disorder: A critical review
    Fountoulakis, KN
    Vieta, E
    Sanchez-Moreno, J
    Kaprinis, SG
    Goikolea, JM
    Kaprinis, GS
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2005, 86 (01) : 1 - 10
  • [2] Treatment guidelines for bipolar disorder: a critical review
    Konstantinos Fountoulakis
    Eduard Vieta
    José Sαnchez-Moreno
    Stergios Kaprinis
    Jose Manuel Goikolea
    George Kaprinis
    [J]. Annals of General Psychiatry, 5 (Suppl 1)
  • [3] Genetics of bipolar disorder: Where do we stand?
    DePaulo, JR
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (04): : 595 - 597
  • [4] Potential biomarkers for bipolar disorder: Where do we stand
    Sagar, Rajesh
    Pattanayak, Raman Deep
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2017, 145 (01) : 7 - 16
  • [5] CHICKENPOX - WHERE DO WE STAND WITH TREATMENT
    WHITLEY, RJ
    [J]. JOURNAL OF PEDIATRICS, 1990, 116 (04): : 587 - 587
  • [6] Where do we stand with IPF treatment?
    Albera, C.
    Ferrero, C.
    Rindone, E.
    Zanotto, S.
    Rizza, E.
    [J]. RESPIRATORY RESEARCH, 2013, 14
  • [7] TREATMENT OF HYPERLIPIDEMIAS - WHERE DO WE STAND
    HAVEL, RJ
    [J]. AMERICAN JOURNAL OF MEDICINE, 1982, 73 (03): : 301 - 304
  • [8] Where do we stand with IPF treatment?
    C Albera
    C Ferrero
    E Rindone
    S Zanotto
    E Rizza
    [J]. Respiratory Research, 14
  • [9] Osteosarcoma treatment - Where do we stand? A state of the art review
    Luetke, Anja
    Meyers, Paul A.
    Lewis, Ian
    Juergens, Heribert
    [J]. CANCER TREATMENT REVIEWS, 2014, 40 (04) : 523 - 532
  • [10] Treatment of negative symptoms: Where do we stand, and where do we go?
    Aleman, Andre
    Lincoln, Tania M.
    Bruggeman, Richard
    Melle, Ingrid
    Arends, Johan
    Arango, Celso
    Knegtering, Henderikus
    [J]. SCHIZOPHRENIA RESEARCH, 2017, 186 : 55 - 62